1. Home
  2. SLQT vs CGTX Comparison

SLQT vs CGTX Comparison

Compare SLQT & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SelectQuote Inc.

SLQT

SelectQuote Inc.

HOLD

Current Price

$0.37

Market Cap

72.4M

Sector

Finance

ML Signal

HOLD

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$0.94

Market Cap

79.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLQT
CGTX
Founded
1985
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.4M
79.6M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
SLQT
CGTX
Price
$0.37
$0.94
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$2.13
★ $3.33
AVG Volume (30 Days)
★ 931.4K
400.1K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 62.79
EPS
★ N/A
N/A
Revenue
★ $1,618,499,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 6.02
N/A
52 Week Low
$0.38
$0.55
52 Week High
$2.22
$2.05

Technical Indicators

Market Signals
Indicator
SLQT
CGTX
Relative Strength Index (RSI) 29.10 43.33
Support Level N/A $0.91
Resistance Level $0.79 $1.18
Average True Range (ATR) 0.03 0.05
MACD 0.00 -0.00
Stochastic Oscillator 7.58 24.53

Price Performance

Historical Comparison
SLQT
CGTX

About SLQT SelectQuote Inc.

SelectQuote Inc is a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. Its insurance distribution business allows consumers to transparently and conveniently shop for senior health, life, and automobile and home insurance policies from a curated panel of the nation's insurance carriers. It operates in three reportable segments: Senior, Healthcare Services, and Life. Senior sells senior Medicare-related health insurance products. Healthcare Services includes SelectRx, Healthcare Select, and SPM. Healthcare Services provides products and services to its Medicare policyholders, which are focused on improving patient health outcomes. Life sells term life and final expense products.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).

Share on Social Networks: